About Dr. Chezhian Subash
Dr. Chezhian Subash, a highly respected hematologist and bone marrow transplant (BMT) expert in India, is widely recognized for his deep expertise in the diagnosis and management of complex hematological malignancies such as multiple myeloma and lymphoma. He has played a pivotal role in advancing alternate donor and mismatched donor transplantation techniques, particularly haploidentical transplants, which offer viable options for patients lacking fully matched donors. Through his commitment to excellence, stringent quality protocols, and training initiatives, Dr. Subash has significantly elevated the standard of hematologic care and advanced blood and marrow transplant procedures in South India.
OPD Schedule Of Dr. Chezhian Subash
Consultation Fees Rs. 800 /-
MIOT International, Chennai
- MBBS, Stanley Medical College, Chennai (1996)
- MRCP (UK) – Royal College of Physicians (2003)
- FRCPath – Haematology – Royal College of Pathologists, UK (2008)
- Royal College of Physicians & Pathologists of London
- British Society of Haematology
- Leukemia (Acute and Chronic)
- Lymphoma (Hodgkin’s and Non-Hodgkin’s)
- Multiple Myeloma
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Neoplasms (MPNs)
- Clinical Hematology
- Hemato-Oncology
- Pediatric Hematology
- Bone Marrow & Stem Cell Transplantation
- Coagulation and Bleeding Disorders
- Anemia and Platelet Disorders
- Thalassemia and Hemoglobinopathies
- Autologous Bone Marrow Transplantation
- Allogeneic Transplantation (Matched Sibling, Haploidentical, Unrelated Donor)
- Stem Cell Harvesting and Transfusion
- Management of Aplastic Anemia and Bone Marrow Failure Syndromes
- Head of Haematology/BMT at MIOT, Chennai (Current)
- Senior Clinical Lecturer for Hull York Medical School
- Led the first-ever T-replete haplo-identical bone marrow transplant performed by MIOT—an advanced and complex procedure.
- Under his leadership, MIOT’s Haematology & BMT unit has completed almost 500 transplants since 2013, maintaining global-average success rates.
- The MIOT centre ranked second in adult bone marrow transplants in Tamil Nadu in 2016
- Maharaja of Cochin Prize (Physiology, 1991)
- K.C. Paul Prize (Clinical Medicine, 1994)
- Hodgkin Lymphoma – Mitigating Toxicity While Preserving Cure
- Pattern of Bacterial Infections in Indian Bone Marrow Transplant Patients – Experience from Chennai, India (Nov 2021)
- Combines global standards with compassionate patient-centered care
- Emphasizes quality and accreditation in hematology services
Treatment Type | Estimated Cost Range (INR) | Estimated Cost Range (USD) |
Bone Marrow Transplant (Allogeneic, Matched Related) | 18,00,000 – 28,00,000 | 21,600 – 33,600 |
Bone Marrow Transplant (Haplo/Alternate Donor) | 22,00,000 – 35,00,000 | 26,400 – 42,000 |
Chemotherapy (per cycle, basic) | 40,000 – 1,20,000 | 480 – 1,450 |
Leukemia/Myeloma/Lymphoma Evaluation Package | 50,000 – 1,00,000 | 600 – 1,200 |